AU599406B2 - Improved estradiol implant composition and method for preparation - Google Patents

Improved estradiol implant composition and method for preparation Download PDF

Info

Publication number
AU599406B2
AU599406B2 AU76724/87A AU7672487A AU599406B2 AU 599406 B2 AU599406 B2 AU 599406B2 AU 76724/87 A AU76724/87 A AU 76724/87A AU 7672487 A AU7672487 A AU 7672487A AU 599406 B2 AU599406 B2 AU 599406B2
Authority
AU
Australia
Prior art keywords
implant
lactide
estradiol
polymer
glycolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU76724/87A
Other languages
English (en)
Other versions
AU7672487A (en
Inventor
Mimi Yih-Pei Chou Schaaf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AU7672487A publication Critical patent/AU7672487A/en
Application granted granted Critical
Publication of AU599406B2 publication Critical patent/AU599406B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
AU76724/87A 1986-08-11 1987-08-10 Improved estradiol implant composition and method for preparation Ceased AU599406B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/895,415 US4758435A (en) 1986-08-11 1986-08-11 Estradiol implant composition and method for preparation
US895415 1986-08-11

Publications (2)

Publication Number Publication Date
AU7672487A AU7672487A (en) 1988-02-18
AU599406B2 true AU599406B2 (en) 1990-07-19

Family

ID=25404471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76724/87A Ceased AU599406B2 (en) 1986-08-11 1987-08-10 Improved estradiol implant composition and method for preparation

Country Status (10)

Country Link
US (1) US4758435A (enExample)
EP (1) EP0257369B1 (enExample)
AT (1) ATE74751T1 (enExample)
AU (1) AU599406B2 (enExample)
CA (1) CA1297020C (enExample)
DE (1) DE3778244D1 (enExample)
ES (1) ES2031096T3 (enExample)
GR (1) GR3004370T3 (enExample)
NZ (1) NZ221390A (enExample)
ZA (1) ZA875897B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU609194B2 (en) * 1987-10-09 1991-04-26 Boehringer Ingelheim International Gmbh Biodegradable implant
AU648278B2 (en) * 1989-11-17 1994-04-21 Procter & Gamble Company, The Sustained release compositions for treating periodontal disease

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5250584A (en) * 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
EP0447719B1 (en) * 1990-03-05 1993-11-03 Minnesota Mining And Manufacturing Company Device for extended delivery of pharmacologically active agents to the ear
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
US5288496A (en) * 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5686092A (en) * 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
ES2359973T3 (es) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
WO2007011707A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
AU2007243268B2 (en) 2006-04-26 2013-06-13 Micell Technologies, Inc. Coatings containing multiple drugs
CA2667890C (en) * 2006-10-31 2015-01-27 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CA2679712C (en) 2007-01-08 2016-11-15 Micell Technologies, Inc. Stents having biodegradable layers
SG192524A1 (en) 2008-04-17 2013-08-30 Micell Technologies Inc Stents having bioabsorbable layers
KR20160029870A (ko) 2008-04-21 2016-03-15 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
WO2010009335A1 (en) 2008-07-17 2010-01-21 Micell Technologies, Inc. Drug delivery medical device
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
MX2011000629A (es) 2008-07-17 2011-04-26 Merial Ltd Formulaciones analgesicas inyectables de larga duracion para animales.
WO2010011605A2 (en) 2008-07-21 2010-01-28 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US9981072B2 (en) 2009-04-01 2018-05-29 Micell Technologies, Inc. Coated stents
EP2419058B1 (en) 2009-04-17 2018-02-28 Micell Technologies, Inc. Stents having controlled elution
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
AU2011271500A1 (en) * 2010-06-30 2013-02-14 Evonik Corporation Implant processing methods for thermally labile and other bioactive agents and implants prepared from same
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CA3082432C (en) * 2011-12-02 2023-01-03 Boehringer Ingelheim Animal Health USA Inc. Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
CA2905419C (en) 2013-03-12 2020-04-28 Micell Technologies, Inc. Bioabsorbable biomedical implants
CA2912387C (en) 2013-05-15 2019-04-16 Micell Technologies, Inc. Bioabsorbable biomedical implants
US10226419B2 (en) 2014-09-08 2019-03-12 ProMed Pharma, LLC Methods for manufacturing implants
CA2993645A1 (en) 2015-07-28 2017-02-02 Otonomy, Inc. Trkb or trkc agonist compositions and methods for the treatment of otic conditions
CN109689027A (zh) 2016-06-29 2019-04-26 奥德纳米有限公司 甘油三酯耳用制剂及其用途
SI3737233T1 (sl) 2018-01-09 2025-10-30 Dompé Farmaceutici S.P.A. Ušesne formulacije z rastnimi faktorji
US20230355542A1 (en) * 2022-05-04 2023-11-09 Yasin Oduk Drug-eluting device with genetic and chemical therapeutics for treating or preventing vascular access dysfunctions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096239A (en) * 1975-04-28 1978-06-20 Syntex Corporation Inert core implant pellet
EP0025698A2 (en) * 1979-09-12 1981-03-25 Eli Lilly And Company Controlled release formulations
EP0122709A1 (en) * 1983-03-18 1984-10-24 Eli Lilly And Company Improvements in or relating to antibiotic or germicide layered implants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
CA1236641A (en) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymer of lactic acid and glycolic acid and method for producing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096239A (en) * 1975-04-28 1978-06-20 Syntex Corporation Inert core implant pellet
EP0025698A2 (en) * 1979-09-12 1981-03-25 Eli Lilly And Company Controlled release formulations
EP0122709A1 (en) * 1983-03-18 1984-10-24 Eli Lilly And Company Improvements in or relating to antibiotic or germicide layered implants

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU609194B2 (en) * 1987-10-09 1991-04-26 Boehringer Ingelheim International Gmbh Biodegradable implant
AU648278B2 (en) * 1989-11-17 1994-04-21 Procter & Gamble Company, The Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
AU7672487A (en) 1988-02-18
GR3004370T3 (enExample) 1993-03-31
DE3778244D1 (de) 1992-05-21
EP0257369A1 (en) 1988-03-02
CA1297020C (en) 1992-03-10
ATE74751T1 (de) 1992-05-15
ES2031096T3 (es) 1992-12-01
US4758435A (en) 1988-07-19
ZA875897B (en) 1988-05-25
EP0257369B1 (en) 1992-04-15
NZ221390A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
AU599406B2 (en) Improved estradiol implant composition and method for preparation
US5427796A (en) Growth promoters for animals
EP0675710B1 (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained
DK171758B1 (da) Implantat til styret frigørelse af et makromolekylært lægemiddel og fremgangsmåde til fremstiling af implantatet
US4393041A (en) Fibrin binder/carrier for active biochemical agents
FI66412C (fi) Eni laekemedelpreparat som baeraraemne anvaendbar sampolyme r om har framstaells genom kondensationspolymerisation frao n joelksyra och glykolsyra och ett foerfarande foer dess fr amtaellning
EP0218148B1 (en) Slow-release pharmaceutical composition
US5091185A (en) Coated veterinary implants
US20020102300A1 (en) Pharmaceuticals formulation
JP2003517014A (ja) 即放性および徐放性成分を含有する医薬インプラントおよび投与方法
US4808412A (en) Rumen-stable compositions
IE920040A1 (en) Bioerodible devices and compositions for diffusional release¹of agents
EP0158277A2 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
TW457099B (en) Sustained release composition of animal growth hormone and process for preparation thereof
US20050118271A1 (en) Polytartrate composition
US5686092A (en) Growth promoters for animals
AU661303B2 (en) Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
Jeyanthi et al. Solid tumour chemotherapy using implantable collagen‐poly (HEMA) hydrogel containing 5‐fluorouracil
US4761289A (en) Sustained release implant and method for preparing same
KR100260632B1 (ko) 이식형 소마토트로핀 조성물
EP0025697B1 (en) Growth promotant controlled release formulations and method of treatment
US3920806A (en) Growth promoting subcutaneous compositions
JPS63203610A (ja) 複数成分からなるインプラント用の持効性医薬製剤
Yoshida et al. Effect of drug–vinyl copolymer delivery composites on the rat prostate
MXPA04011796A (es) Unidades de dosificacion progestagenica.